JP2018502600A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018502600A5 JP2018502600A5 JP2017552233A JP2017552233A JP2018502600A5 JP 2018502600 A5 JP2018502600 A5 JP 2018502600A5 JP 2017552233 A JP2017552233 A JP 2017552233A JP 2017552233 A JP2017552233 A JP 2017552233A JP 2018502600 A5 JP2018502600 A5 JP 2018502600A5
- Authority
- JP
- Japan
- Prior art keywords
- lactic acid
- plasmid
- seq
- amino acid
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1451658 | 2014-12-23 | ||
| SE1451658-7 | 2014-12-23 | ||
| PCT/EP2015/081146 WO2016102660A1 (en) | 2014-12-23 | 2015-12-23 | Methods for wound healing |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019156412A Division JP7033109B2 (ja) | 2014-12-23 | 2019-08-29 | 創傷治癒の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018502600A JP2018502600A (ja) | 2018-02-01 |
| JP2018502600A5 true JP2018502600A5 (enExample) | 2018-03-22 |
| JP6581208B2 JP6581208B2 (ja) | 2019-09-25 |
Family
ID=55080095
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017552233A Active JP6581208B2 (ja) | 2014-12-23 | 2015-12-23 | 創傷治癒の方法 |
| JP2019156412A Active JP7033109B2 (ja) | 2014-12-23 | 2019-08-29 | 創傷治癒の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019156412A Active JP7033109B2 (ja) | 2014-12-23 | 2019-08-29 | 創傷治癒の方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US10696974B2 (enExample) |
| EP (2) | EP3237622B1 (enExample) |
| JP (2) | JP6581208B2 (enExample) |
| KR (2) | KR102081493B1 (enExample) |
| CN (2) | CN113403244B (enExample) |
| AU (2) | AU2015370982B2 (enExample) |
| CA (1) | CA2971520C (enExample) |
| ES (2) | ES3048233T3 (enExample) |
| WO (1) | WO2016102660A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3408378B1 (en) | 2016-01-25 | 2022-01-12 | NantCell, Inc. | Nk cells with altered cxcl12/cxcr4 signaling |
| BR112019007812A2 (pt) * | 2016-10-31 | 2019-07-16 | Kimberly Clark Co | métodos para arquivar e de recriar um microbioma. |
| US20240024388A1 (en) * | 2017-02-17 | 2024-01-25 | The University Of British Columbia | Probiotic compositions and uses thereof |
| CN110157733A (zh) * | 2018-02-11 | 2019-08-23 | 四川大学 | 重组mIL-22BP载体、脂质体复合物及其制备方法和用途 |
| EP3827102A1 (en) * | 2018-07-24 | 2021-06-02 | Biogaia AB | Therapeutic methods using bacterial strains which are capable of increasing adenosine levels |
| US11911424B2 (en) * | 2018-07-24 | 2024-02-27 | Biogaia Ab | Selection and use of melatonin supporting bacteria to reduce infantile colic |
| CN109112155A (zh) * | 2018-08-02 | 2019-01-01 | 南昌大学 | 乳酸乳球菌mg1363的构建及其在治疗细菌性阴道炎中的应用 |
| CN109517772A (zh) * | 2018-10-30 | 2019-03-26 | 南昌大学 | 一种乳酸乳球菌mg1363的构建及其在治疗产妇乳头皲裂中的应用 |
| CN109234298A (zh) * | 2018-10-30 | 2019-01-18 | 南昌大学 | 一种卷曲乳杆菌atcc55221的构建及其在治疗产妇乳头皲裂中的应用 |
| JP7045671B2 (ja) * | 2018-11-12 | 2022-04-01 | 有限会社バイオ研 | 皮膚塗布用の皮膚創傷治癒促進組成物、その製造方法、及び創傷被覆材 |
| JP7525911B2 (ja) * | 2019-06-24 | 2024-07-31 | メンデス・ソシエタ・ア・レスポンサビリタ・リミタータ | プロバイオティクスを含む抗菌および再上皮化作用を有する組成物 |
| CN110623792B (zh) * | 2019-09-23 | 2022-05-06 | 温州医科大学附属第一医院 | 一种医学敷料及其制备方法 |
| CN114470007B (zh) * | 2020-11-13 | 2024-10-18 | 葡萄王生技股份有限公司 | 含乳酸菌发酵产物之皮肤创伤外用组合物及其用途 |
| JPWO2023063314A1 (enExample) | 2021-10-11 | 2023-04-20 | ||
| WO2023118327A1 (en) | 2021-12-22 | 2023-06-29 | Ilya Pharma Ab | Live bacteria as excipients for proteins |
| KR20240131363A (ko) * | 2021-12-29 | 2024-08-30 | 일리야 팔마 에이비 | 요법-유도된 장병증의 치료 |
| KR102752056B1 (ko) * | 2023-07-12 | 2025-01-13 | 전남대학교 산학협력단 | 락토바실러스 루터리(Lactobacillus reuteri) NCHBL-005 균주를 포함하는 창상 예방 또는 치료, 피부 재생 촉진용 조성물 |
| GB202405882D0 (en) | 2024-04-26 | 2024-06-12 | Ilya Pharma Ab | Treatment of mdr infections |
| CN118948906B (zh) * | 2024-10-16 | 2025-02-14 | 温州医科大学附属第一医院 | 一种促进创面愈合的乳酸杆菌生物膜衍生物及其制备方法和应用 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9521568D0 (en) * | 1995-10-20 | 1995-12-20 | Lynxvale Ltd | Delivery of biologically active polypeptides |
| CA2279461A1 (en) * | 1997-02-07 | 1998-08-13 | Shionogi & Co., Ltd. | Novel mouse cxc chemokine receptor |
| ES2272311T3 (es) | 1999-07-05 | 2007-05-01 | Vlaams Interuniversitair Instituut Voor Biotechnologie | Suministro de peptidos trebol. |
| CA2311201A1 (en) | 1999-08-05 | 2001-02-05 | Genset S.A. | Ests and encoded human proteins |
| US7780961B2 (en) | 2001-05-03 | 2010-08-24 | Actogenix N.V. | Self-containing Lactococcus strain |
| US7776564B2 (en) * | 2004-04-30 | 2010-08-17 | Five Prime Therapeutics, Inc. | Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use |
| WO2006018446A2 (en) | 2004-08-20 | 2006-02-23 | Actogenix Nv | Method to improve lactococcus preservation |
| JP5049973B2 (ja) | 2005-08-30 | 2012-10-17 | アクトジェニックス・エヌブイ | 慢性全腸炎の治療のための、抗−ＴＮＦα産生乳酸菌 |
| US20080254014A1 (en) | 2005-10-03 | 2008-10-16 | Actogenix N V | Use of Recombinant Yeast Strain Producing an Anti-Inflammatory Compound to Treat Colitis |
| DK2119450T3 (da) | 2005-11-29 | 2013-05-06 | Actogenix Nv | Induktion af mucosal tolerance over for pankreatisk ø-beta-celle-autoantigener |
| US8852916B2 (en) | 2010-01-22 | 2014-10-07 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with microorganisms |
| US8682619B2 (en) * | 2005-12-14 | 2014-03-25 | The Invention Science Fund I, Llc | Device including altered microorganisms, and methods and systems of use |
| EP3255149A3 (en) | 2006-05-02 | 2018-04-18 | Intrexon Actobiotics NV | Microbial intestinal delivery of obesity related peptides |
| CA2672229A1 (en) | 2006-12-14 | 2008-06-19 | Actogenix N.V. | Delivery of binding molecules to induce immunomodulation |
| WO2008074331A1 (en) | 2006-12-19 | 2008-06-26 | Ferrosan A/S | Wound or tissue dressing comprising lactic acid bacteria |
| RU2009127718A (ru) | 2006-12-19 | 2011-01-27 | Ферросан А/С (Dk) | Раневой или тканевой перевязочный материал, содержащий молочнокислые бактерии |
| CN101605900B (zh) | 2007-01-12 | 2014-04-23 | 阿克图杰尼斯公司 | 乳球菌启动子和其用途 |
| BRPI0807857A2 (pt) | 2007-01-25 | 2014-05-27 | Actogenix Nv | Tratamento de doença imune por meio de distribuição através da mucosa de antígenos. |
| US20110044945A1 (en) * | 2007-02-08 | 2011-02-24 | Rappaport Family Institute For Research In The Medical Sciences | Agents for the treatment of multiple sclerosis and methods of using same |
| EP2164512A2 (en) | 2007-06-20 | 2010-03-24 | Actogenix N.V. | Methods and compositions for treating mucositis |
| ATE543507T1 (de) | 2007-11-07 | 2012-02-15 | Ono Pharmaceutical Co | Sdf-1 enthaltende zusammensetzung mit anhaltender freisetzung |
| AU2008338525B2 (en) | 2007-12-14 | 2015-04-02 | Juventas Therapeutics, Inc. | Compositions and methods of promoting wound healing |
| US8367109B2 (en) | 2008-04-09 | 2013-02-05 | Brookhaven Science Associates, Llc | Microbes encapsulated within crosslinkable polymers |
| JP2012504116A (ja) | 2008-09-29 | 2012-02-16 | アクトジェニックス・エヌブイ | 粘膜での微生物のコロニー形成の低減 |
| US20100143305A1 (en) * | 2008-12-08 | 2010-06-10 | James Allen Lemke | Treatment of hiv and aids using probiotic lactobacillus reuteri |
| CN102421894A (zh) | 2009-04-21 | 2012-04-18 | 迈阿密大学 | 用于促进局部缺血性和糖尿病性创面愈合的组合物、试剂盒和方法 |
| EP2243487A1 (en) | 2009-04-23 | 2010-10-27 | Actogenix N.V. | Enteric coated formulation |
| ES2425385T3 (es) | 2009-04-30 | 2013-10-15 | Actogenix N.V. | Crioprotectores para la liofilización de las bacterias de ácido láctico |
| US20100310514A1 (en) * | 2009-06-04 | 2010-12-09 | Chi Hin Cho | Anti-Inflammatory Bacteria |
| CL2009001506A1 (es) | 2009-07-01 | 2009-09-25 | Univ Concepcion | Parche o aposito a base de hidrocoloides compuesto por una lamina de gelatina reticulada que comprende cepas viables probioticas productoras de acido lactico de lactobacillus acidophilus dsm 17371, un agente reticulante y un agente plastificante; y proceso para elaborar dicho parche. |
| CA2772610C (en) | 2009-08-28 | 2018-01-23 | The Cleveland Clinic Foundation | Sdf-1 delivery for treating ischemic tissue |
| EP3192873A1 (en) | 2009-09-29 | 2017-07-19 | Intrexon Actobiotics NV | Lactobacillus and streptococcus promoters and uses thereof |
| GB2482536B (en) * | 2010-08-05 | 2013-07-24 | Hera Pharmaceuticals Inc | Expression of antibody or a fragment thereof in lactobacillus |
| CN101985052B (zh) | 2010-08-31 | 2013-11-06 | 中国人民解放军第二军医大学 | 自动捕获内皮祖细胞促进血管化的皮肤替代物及其构建方法 |
| WO2012150269A1 (en) | 2011-05-03 | 2012-11-08 | Dupont Nutrition Biosciences Aps | Probiotic bacteria for the topical treatment of skin disorders |
| EP2714912B1 (en) | 2011-06-01 | 2018-05-02 | Intrexon Actobiotics NV | Polycistronic expression system for bacteria |
| HUE038830T2 (hu) | 2011-09-23 | 2018-11-28 | Intrexon Actobiotics Nv | Módosított gram-pozitív baktériumok és alkalmazásaik |
| CN103917639B (zh) | 2011-09-23 | 2017-09-26 | 英特瑞克斯顿阿克图比奥帝克斯有限公司 | 经修饰的革兰氏阳性细菌及其用途 |
| GB201206599D0 (en) * | 2012-04-13 | 2012-05-30 | Univ Manchester | Probiotic bacteria |
| AU2014233266A1 (en) | 2013-03-15 | 2015-10-22 | Juventas Therapeutics, Inc. | The use of SDF-1 to mitigate scar formation |
| WO2014146202A1 (en) * | 2013-03-18 | 2014-09-25 | London Health Sciences Centre Research Inc. | Bacteria for the prevention, treatment and diagnosis of breast cancer |
| EP4091609A1 (en) | 2013-04-29 | 2022-11-23 | Medregen, LLC | Wound healing via autologous stem cell mobilization |
| WO2016124239A1 (en) | 2015-02-04 | 2016-08-11 | Aurealis Oy | Recombinant probiotic bacteria for use in the treatment of a skin dysfunction |
-
2015
- 2015-12-23 EP EP15822941.9A patent/EP3237622B1/en active Active
- 2015-12-23 WO PCT/EP2015/081146 patent/WO2016102660A1/en not_active Ceased
- 2015-12-23 CN CN202110680754.6A patent/CN113403244B/zh active Active
- 2015-12-23 US US15/538,384 patent/US10696974B2/en active Active
- 2015-12-23 EP EP20161504.4A patent/EP3735979B1/en active Active
- 2015-12-23 CA CA2971520A patent/CA2971520C/en active Active
- 2015-12-23 KR KR1020177020505A patent/KR102081493B1/ko active Active
- 2015-12-23 ES ES20161504T patent/ES3048233T3/es active Active
- 2015-12-23 ES ES15822941T patent/ES2864373T3/es active Active
- 2015-12-23 CN CN201580070791.8A patent/CN107208107B/zh active Active
- 2015-12-23 KR KR1020207004865A patent/KR102297619B1/ko active Active
- 2015-12-23 JP JP2017552233A patent/JP6581208B2/ja active Active
- 2015-12-23 AU AU2015370982A patent/AU2015370982B2/en active Active
-
2019
- 2019-06-19 AU AU2019204290A patent/AU2019204290B2/en active Active
- 2019-08-29 JP JP2019156412A patent/JP7033109B2/ja active Active
-
2020
- 2020-06-05 US US16/893,781 patent/US11473091B2/en active Active
-
2022
- 2022-08-11 US US17/819,274 patent/US20230093013A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6866974B2 (ja) | 新規なエンドリシンポリペプチド | |
| Nishie et al. | Antibacterial peptides “bacteriocins”: an overview of their diverse characteristics and applications | |
| JP2021501581A5 (enExample) | ||
| NZ602943A (en) | Modified binding proteins inhibiting the vegf-a receptor interaction | |
| MX2018009225A (es) | Inmunoterapia basada en vectores de distribución personalizados y usos de la misma. | |
| HRP20241279T1 (hr) | Pripravak koji sadrži probiotike koji prekomjerno eksprimiraju protein clpb za uporabu u liječenju pretilosti | |
| Chen et al. | Cloning and heterologous expression of a bacteriocin sakacin P from Lactobacillus sakei in Escherichia coli | |
| CN106232616A (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 | |
| RU2017142932A (ru) | Фармацевтические и пищевые композиции для индуцирования насыщения и продления сытости у нуждающихся в этом субъектов | |
| WO2017084985A1 (en) | Bacteriocin composition and method | |
| MX2023015156A (es) | Peptidos antimicrobianos modificados. | |
| Sivaraj et al. | Potential applications of lactic acid bacteria and bacteriocins in anti-mycobacterial therapy | |
| JP2013542942A5 (enExample) | ||
| ES2808780T3 (es) | Nuevos péptidos antimicrobianos, sus variantes y usos | |
| WO2010012972A3 (en) | Novel bacterial cells and uses thereof | |
| Niu et al. | Full‐length cDNA, prokaryotic expression, and antimicrobial activity of UuHb‐F‐I from Urechis unicinctus | |
| IL297430A (en) | Chimeric endolysin polypeptide | |
| Peng et al. | Tissue distribution, expression, and antimicrobial activity of Anas platyrhynchos avian β-defensin 6 | |
| WO2019033007A3 (en) | Staphylococcus pseudintermedius virulence factor compositions | |
| WO2019059817A9 (en) | VACCINE BASED ON FUSION PROTEIN AND PLASMIDIC DNA | |
| CN106749534B (zh) | 一种许氏平鮋抗菌肽bs20及其应用 | |
| US11648289B2 (en) | Antibacterial method | |
| Shen et al. | Expression of a novel dual-functional protein–the antimicrobial peptide LL-37 fused with human acidic fibroblast growth factor in Escherichia coli | |
| JP2019510519A5 (enExample) | ||
| CN107949568B (zh) | 新抗微生物肽、它们的变体和用途 |